News Jan 8, 2024 Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective… Read Now
Article Nov 9, 2023 2023 Size of the CRO Market We recently published a summary article on the size of the contract research market for the period of 2023 to 2028. We collated data from multiple sources…. Read Now
News Nov 8, 2023 Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials. LONDON, ON, November 8, 2023 – Alimentiv Inc., AcelaBio Inc., and PharmaNest Inc. are pleased to announce their collaborative effort aimed at revolutionizing precision medicine… Read Now
News Oct 13, 2023 Alimentiv Inc. Announces New Scientific Advisors Leading Research In GI-Related Therapeutics London, Ontario, Canada, October 13, 2023, Alimentiv Inc. (“Alimentiv”), a leading Contract Research Organization focused on GI-related therapeutics, is pleased to announce the addition of… Read Now
Article Oct 11, 2023 Ultimate Guide to Contract Research Organization Market Size Due to Contract Research Organizations’ (CROs) significant impact on drug development and healthcare advancements, understanding the size and future growth of the CRO Market is… Read Now
News Oct 10, 2023 Alimentiv and Satisfai Health Announce Commercial Availability of Highly Innovative AI-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical Trials London, Canada and Vancouver, Canada – Alimentiv, a global contract research organization (CRO) providing clinical trials, central image management, precision medicine, and real-world evidence services… Read Now
